<p dir="ltr" style="line-height: 1.38; margin-top: 12pt; margin-bottom: 12pt;">[size= 12pt; font-family: Calibri, sans-serif; background-color: transparent; font-weight: bold; font-variant: normal; vertical-align: baseline; white-space: pre-wrap]
[/size][size= 12pt; font-family: Calibri, sans-serif; background-color: transparent; font-weight: bold; font-variant: normal; vertical-align: baseline; white-space: pre-wrap] The [/size][size= 12pt; font-family: Calibri, sans-serif; color: #1155cc; background-color: transparent; font-weight: bold; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap]import drug license[/size][size= 12pt; font-family: Calibri, sans-serif; background-color: transparent; font-weight: bold; font-variant: normal; vertical-align: baseline; white-space: pre-wrap] process in India involves applying to CDSCO with Form 8 and 9, along with product details, manufacturing site licenses, and test reports. CDSCO evaluates safety, efficacy, and quality before granting approval under the Drugs and Cosmetics Act, 1940.[/size]

[size= 12pt; font-family: Calibri, sans-serif; background-color: transparent; font-weight: bold; font-variant: normal; vertical-align: baseline; white-space: pre-wrap] [/size]